ClinicalTrials.Veeva

Menu

PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark

A

Aarhus University Hospital

Status

Active, not recruiting

Conditions

Anal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05570279
KFE-1523

Details and patient eligibility

About

The study is a prospective registration of treatment related-, toxicity-, Quality of life- and outcome data from patients treated in Denmark with radiotherapy for squamous cell carcinoma of the anus (SCCA), as a cooperation within the Danish Anal Cancer Group (DACG).

Substudy one: A prospective biobank is collected with the purpose to identify predictive and prognostic markers for outcome.

Substudy two: MRI scans are performed to investigate the rate of pelvic insufficience fractures at one year post chemoradiotherapy.

Enrollment

314 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18
  • Squamous cell carcinoma of the anus, and indication for curatively intended radiotherapy
  • Written and oral consent

Exclusion criteria

  • Contraindication to blood sampling or MRI scans (substudy 1 and 2)
  • Other malignant disease within 5 years except from basal cell carcinomas

Trial contacts and locations

3

Loading...

Central trial contact

Karen-Lise G Spindler, Professor; Karen-Lise G Spindler, DMSc, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems